China growth & Massive revenue ahead
11/11 sales in China according to a2m USA investor presentation
a2m sales for infant formula was the #2nd best brand seller over all and stage 3 the Top selling product overall
So what happens when we have enough product to match 11/11 sales does a2m get to be the #1 infant formula seller in China, will we have 14% of infant formula market or more ??
Will New Zealand 10% and a2m surpass Netherlands 34%, if a2m is #1 infant formula seller that means potentially a2m could have 34% of infant formula thats imported to China ??
Remembering Chinese buyers and majority of public consumers still don't know the true a2 protein health benefit positives yet, imagine once this is fully comprehended what it would do to a2m revenue.
Join the dots and simple maths says a2m has a LONG LONG way to go in revenue growth ahead and market share.
JH & BOD massive media spend is a great investment for the huge future revenue growth ahead..
Graphs might be old but it all heads to massive future ahead, maybe someone will have crack at taking out a2m but it will cost them plenty.
I personally want to see a2m do it alone as its future is already set to flourish...
Compounding growth to come will be huge and will be many great days ahead for long term share holders.
Cheers TD
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-4835
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.45 |
Change
0.640(13.3%) |
Mkt cap ! $3.808B |
Open | High | Low | Value | Volume |
$5.59 | $5.72 | $5.38 | $59.39M | 10.71M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 50150 | $5.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.45 | 77730 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | 5.630 |
6 | 17273 | 5.610 |
4 | 33072 | 5.600 |
4 | 20359 | 5.590 |
2 | 7656 | 5.580 |
Price($) | Vol. | No. |
---|---|---|
5.650 | 7091 | 2 |
5.670 | 9037 | 3 |
5.680 | 9833 | 4 |
5.690 | 6747 | 2 |
5.700 | 8222 | 4 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online